Patent Assignment
Reel/Frame 016177/0256
Assignment of Assignor's Interest
Recorded: 2005-06-22
Pages: 3
Assignee
XCYTE THERAPIES, INC.
1124 COLUMBIA STREET, SUITE 130, SEATTLE, WASHINGTON, 98104
Covered Property
(1)
T cell therapy for the treatment of cachexia and chronic diseases
Application:
11/091,361 →
Publication:
US 2005/0226857
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 26, 2006
From: XCYTE THERAPIES, INC.
To: INVITROGEN CORPORATION
Reel/Frame 018303/0117 →
Security Agreement
Dec 5, 2008
From: LIFE TECHNOLOGIES CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 021975/0467 →
Merger
Feb 3, 2010
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 023882/0551 →
Lien Release
Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 030182/0461 →
Corrective Assignment to Correct the Application No 09452626 Previously Recorded on Reel 023882 Frame 0551. Assignor(S) Hereby Confirms the Merger Should Not Have Been Recorded Against This Patent Application Number.
Nov 14, 2014
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 034217/0490 →